GO:1990839 response to endothelin: Vasoconstrictor Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990839 (response to endothelin) describes any cellular or organismal change triggered by endothelin-1, -2, or -3, three secretory vasoconstrictive peptides.
• Endothelin-1 is one of the most potent vasoconstrictors known and contributes to hypertension, pulmonary hypertension, and cardiovascular remodeling [2,4].
• The response involves G-protein-coupled receptor signaling, inositol lipid turnover, calcium mobilization, and sustained pressor effects [5,8].
• Endothelin-1 potentiates the actions of other vasoactive agents such as angiotensin II and oxytocin, amplifying contractile responses [1,6].
• Dysregulated endothelin responses are implicated in pulmonary hypertension associated with Pneumocystis infection and in spontaneous hypertension models [7,8].
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of endothelin pathway genes in vascular and non-vascular tissues [5,7].
Description
GO:1990839, response to endothelin, is a biological process Gene Ontology term that captures the full spectrum of cellular and organismal changes elicited by endothelin peptides. Endothelin-1, endothelin-2, and endothelin-3 are 21-amino-acid secretory vasoconstrictive peptides that act through G-protein-coupled receptors to regulate vascular tone, hormone secretion, and gene expression. Since its discovery, endothelin-1 has been recognized as one of the most potent endogenous vasoconstrictors, and its response pathway is central to cardiovascular physiology and pathology [2,4]. Researchers study GO:1990839 to understand how a single peptide stimulus can produce sustained pressor responses, modulate other hormonal systems, and drive tissue remodeling in hypertension and pulmonary disease [1,4,7]. The term is also relevant beyond the vasculature: endothelin signaling influences contractility in reproductive tissues and inositol lipid-mediated signaling in the testis, illustrating its broad biological reach [5,6]. Because endothelin responses are amplified in disease states such as spontaneous hypertension and Pneumocystis-associated pulmonary hypertension, the pathway is a target for mechanistic and therapeutic studies [7,8]. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:1990839, its molecular players, disease links, and CRISPR-based methods for functional interrogation.
response to endothelin At A Glance
| GO ID | GO:1990839 |
|---|---|
| GO term | response to endothelin |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that results in a change in state or activity of a cell or an organism as a result of an endothelin stimulus; endothelin is any of three secretory vasoconstrictive peptides (endothelin-1, -2, -3). |
| Major function | Mediates cellular and systemic responses to endothelin peptides, including vasoconstriction, hormone secretion, and gene expression changes [2,4]. |
| Stimulus | Endothelin-1, endothelin-2, or endothelin-3 peptides. |
| Representative physiology | Pressor response, vascular tone regulation, and potentiation of other vasoactive agents [1,8]. |
| Disease relevance | Hypertension, pulmonary hypertension, and cardiovascular remodeling [4,7,8]. |
What Is GO:1990839?
In our own words, GO:1990839 response to endothelin refers to any process that results in a change in the state or activity of a cell or an organism as a result of an endothelin stimulus. These changes can include movement, secretion, enzyme production, gene expression, and other cellular activities. Endothelin is any of three secretory vasoconstrictive peptides: endothelin-1, endothelin-2, and endothelin-3. The term therefore encompasses signal reception, intracellular transduction, and downstream physiological outputs triggered by these peptides.
Why Is response to endothelin Important in Cell Biology?
GO:1990839 is important because endothelin peptides are among the most potent vasoconstrictors in human physiology, and their response pathway is a major determinant of vascular tone, blood pressure, and tissue perfusion [2,4]. Dysregulated endothelin responses contribute to hypertension, pulmonary hypertension, and cardiovascular remodeling, making the pathway a clinically relevant target [4,7,8]. Understanding this process also illuminates how a single peptide can potentiate other hormonal systems, such as angiotensin II and oxytocin, thereby amplifying physiological outputs [1,6]. For researchers, GO:1990839 provides a framework to dissect receptor-proximal signaling, inositol lipid turnover, and downstream gene expression changes in diverse tissues.
• Endothelin-1 is a highly potent vasoconstrictor central to blood pressure regulation.
• The response pathway contributes to hypertension and cardiovascular remodeling.
• Endothelin-1 augments the pressor response to angiotensin II infusion in rats.
• Endothelin-1 potentiates oxytocin-induced contraction in pregnant human myometrium.
• Inositol lipid-mediated signaling is a key feature of endothelin responses in mammalian testis.
• Pulmonary hypertension associated with Pneumocystis infection involves altered endothelin responses.
• Spontaneously hypertensive rats show altered pressor responses to endothelin.
• Endothelin signaling is studied across vascular, reproductive, and pulmonary systems [5,6,7].
• The pathway is a target for therapeutic intervention in cardiovascular disease.
• CRISPR models enable causal testing of endothelin pathway genes in vivo and in vitro [5,7].
What Happens During response to endothelin?
Endothelin stimulus and receptor engagement
In simple terms: Endothelin peptides bind to receptors on the cell surface, starting the response.
The response to endothelin begins when one of the three secretory vasoconstrictive peptides, endothelin-1, -2, or -3, engages its cognate receptors on target cells. Endothelin-1 is the most extensively characterized isoform and acts as a potent vasoconstrictor in the vasculature [2,4]. Receptor engagement initiates intracellular signaling cascades that convert the extracellular peptide stimulus into changes in cell state and activity.
Inositol lipid-mediated signal transduction
In simple terms: Inside the cell, lipids are broken down to produce messengers that amplify the signal.
A key intracellular event in the response to endothelin is inositol lipid-mediated signaling. Studies in mammalian testis demonstrate that endothelin, like ATP, triggers inositol lipid turnover, generating second messengers that propagate the signal. This lipid-based transduction is a conserved feature of endothelin responses and links receptor activation to downstream calcium mobilization and enzyme activation.
Vascular contractile and pressor responses
In simple terms: Blood vessels tighten, raising blood pressure.
Endothelin-1 elicits potent and sustained vasoconstriction, producing a pressor response in vivo [2,8]. In spontaneously hypertensive and Wistar-Kyoto rats, the pressor response to endothelin has distinct characteristics, indicating that the response magnitude and kinetics are influenced by genetic background. Endothelin-1 also augments the pressor response to angiotensin II infusion in rats, showing that it potentiates other vasoactive systems.
Modulation of smooth muscle and reproductive tissue contractility
In simple terms: Endothelin makes muscles contract more strongly, including in the uterus.
Beyond the vasculature, endothelin-1 potentiates the in vitro contractile response of pregnant human myometrium to oxytocin, demonstrating that the response to endothelin extends to reproductive smooth muscle. This potentiation indicates that endothelin can sensitize tissues to other contractile agonists, amplifying physiological outputs.
Integration with pulmonary and systemic pathophysiology
In simple terms: In disease, the endothelin response can become harmful, contributing to high blood pressure in the lungs.
In Pneumocystis-associated pulmonary hypertension, vascular dysfunction is related to the endothelin response and adrenomedullin concentration, linking the pathway to infectious and inflammatory lung disease. In systemic hypertension, endothelin contributes to vascular remodeling and elevated blood pressure. These findings position the response to endothelin as a central node integrating vasoactive, hormonal, and inflammatory signals [4,7].
Key Genes Involved in GO:1990839 response to endothelin
The following genes and proteins are central to the response to endothelin, based on verified literature covering endothelin peptides, their receptors, and downstream signaling components.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EDN1 | Encodes endothelin-1, the principal vasoconstrictive peptide ligand | Central to pressor responses and hypertension models [1,2,8] |
| EDN2 | Encodes endothelin-2, a secretory vasoconstrictive peptide | Part of the endothelin family stimulus defined in GO:1990839 |
| EDN3 | Encodes endothelin-3, a secretory vasoconstrictive peptide | Part of the endothelin family stimulus defined in GO:1990839 |
| EDNRA | Endothelin receptor type A, mediates vasoconstriction | Key receptor for endothelin-1 pressor and contractile effects [1,6] |
| EDNRB | Endothelin receptor type B, mediates vasodilation and clearance | Modulates overall endothelin response and vascular tone [2,4] |
| AGTR1 | Angiotensin II receptor type 1, interacts with endothelin pressor effects | Endothelin-1 augments angiotensin II pressor response |
| OXTR | Oxytocin receptor, mediates myometrial contraction potentiated by endothelin-1 | Endothelin-1 potentiates oxytocin contractile response |
| PLCB1 | Phospholipase C beta 1, generates inositol lipid second messengers | Inositol lipid-mediated signaling in response to endothelin |
| ITPR1 | Inositol 1,4,5-trisphosphate receptor, releases calcium | Downstream of inositol lipid signaling in endothelin response |
| ADM | Adrenomedullin, vasodilatory peptide linked to endothelin response | Vascular dysfunction in Pneumocystis-associated pulmonary hypertension |
| NOS3 | Endothelial nitric oxide synthase, modulates vascular tone | Counter-regulates endothelin-mediated vasoconstriction |
| ACE | Angiotensin-converting enzyme, produces angiotensin II | Interacts with endothelin in pressor responses |
| REN | Renin, rate-limiting enzyme in angiotensin system | Systemic partner of endothelin in blood pressure regulation |
| CALM1 | Calmodulin, calcium sensor in contractile signaling | Downstream of calcium mobilization in endothelin response |
| MYH11 | Smooth muscle myosin heavy chain, contractile machinery | Effector of endothelin-induced smooth muscle contraction |
| ACTG2 | Smooth muscle actin gamma 2, contractile apparatus | Effector of endothelin-induced contractility |
| GNAQ | G protein alpha q, couples receptors to phospholipase C | Proximal transducer in endothelin receptor signaling |
| PRKCA | Protein kinase C alpha, modulates downstream signaling | Regulatory node in endothelin response |
How Is response to endothelin Regulated?
The response to endothelin is regulated at multiple levels. Receptor density and subtype balance influence the magnitude of the response, with EDNRA mediating vasoconstriction and EDNRB contributing to clearance and vasodilation [2,4]. Inositol lipid-mediated signaling provides a tunable amplification step, as demonstrated in mammalian testis where endothelin and ATP both engage this pathway. Systemic factors such as angiotensin II and oxytocin modulate the response, with endothelin-1 potentiating their effects [1,6]. In disease states, including spontaneous hypertension and Pneumocystis-associated pulmonary hypertension, the response is altered, suggesting that genetic and inflammatory inputs reshape pathway regulation [7,8].
response to endothelin and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EDN1 | Hypertension and pressor response | Edn1 knockout or overexpression in rodent models [1,8] |
| EDNRA | Vascular remodeling and vasoconstriction | Ednra conditional knockout in smooth muscle |
| ADM | Pneumocystis-associated pulmonary hypertension | Adm knockout or knock-in in pulmonary vascular models |
| OXTR | Myometrial contractility disorders | Oxtr knockout in pregnant myometrium models |
| AGTR1 | Renin-angiotensin-endothelin crosstalk in hypertension | Agtr1 knockout with endothelin infusion |
Hypertension and cardiovascular remodeling
Endothelin is a key mediator of hypertension and vascular remodeling, and its response pathway contributes to elevated blood pressure and cardiovascular pathology. In spontaneously hypertensive rats, the pressor response to endothelin differs from normotensive controls, indicating that genetic background shapes the pathological response. Endothelin-1 also augments the pressor response to angiotensin II, linking the pathway to renin-angiotensin system-driven hypertension.
Pulmonary hypertension and infectious lung disease
Vascular dysfunction in Pneumocystis-associated pulmonary hypertension is related to the endothelin response and adrenomedullin concentration, connecting the pathway to infectious and inflammatory pulmonary disease. This suggests that endothelin responses contribute to pulmonary vascular remodeling in the setting of infection.
Reproductive tissue contractility
Endothelin-1 potentiates the in vitro contractile response of pregnant human myometrium to oxytocin, indicating a role in reproductive smooth muscle regulation. This has implications for understanding uterine contractility and related disorders.
From response to endothelin-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does EDN1 loss reduce pressor response? | EDN1 knockout rodent or cell model [1,8] |
| Does a point mutation in EDNRA alter ligand binding? | EDNRA point-mutation knock-in |
| Can tagged EDN1 track secretion dynamics? | Tagged EDN1 knock-in |
| Does EDN1 overexpression amplify angiotensin II response? | EDN1 overexpression model |
| Is ADM causally linked to pulmonary hypertension? | ADM knockout or overexpression in lung vasculature |
| Does OXTR mediate endothelin potentiation in myometrium? | OXTR knockout myometrial tissue |
How to Study the response to endothelin Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes after endothelin stimulation | Identify downstream genes in GO:1990839 |
| Inositol phosphate turnover assay | Phospholipase C activity and second messenger production | Dissect inositol lipid signaling |
| Calcium imaging | Intracellular calcium mobilization | Measure proximal signaling after endothelin |
| Vascular ring assay | Smooth muscle contractile response | Test endothelin-1 potency and potentiation |
| In vivo pressor measurement | Blood pressure response to endothelin | Assess systemic response in hypertension models [1,8] |
| ELISA for adrenomedullin | Adrenomedullin concentration in disease models | Link endothelin response to pulmonary hypertension |
| Western blot | Protein expression and phosphorylation changes | Validate signaling nodes in endothelin response |
| Immunohistochemistry | Tissue localization of endothelin pathway proteins | Assess vascular and tissue distribution |
Transcriptomic profiling of endothelin responses
RNA sequencing can quantify gene expression changes following endothelin stimulation, revealing downstream transcriptional programs activated by endothelin-1, -2, or -3 [2,5]. This approach helps identify genes whose expression is altered as part of GO:1990839.
Inositol lipid and calcium signaling assays
Because inositol lipid-mediated signaling is a hallmark of endothelin responses, assays measuring inositol phosphate turnover and intracellular calcium mobilization are valuable for dissecting the pathway. These methods can be applied in cell lines and primary tissues.
Vascular reactivity and pressor response measurements
In vivo pressor response measurements and in vitro vascular ring assays quantify the functional output of endothelin responses, including potentiation of angiotensin II and oxytocin effects [1,6,8]. These physiological readouts are essential for linking molecular changes to organismal phenotypes [1,8].
Disease model phenotyping
Pulmonary hypertension and hypertension models can be phenotyped for endothelin response and adrenomedullin concentration to connect the pathway to disease [7,8]. Such studies integrate molecular, physiological, and pathological data.
How CRISPR Can Be Used to Study GO:1990839 response to endothelin
Knockout
CRISPR knockout of EDN1, EDNRA, or downstream signaling genes can abolish or reduce the response to endothelin, providing causal evidence for their roles in vasoconstriction and pressor responses [1,4,8]. Knockout models are particularly useful for testing whether a candidate gene is required for the full response.
Point Mutation
Point mutations in receptor or signaling genes can dissect specific residues required for ligand binding, G-protein coupling, or downstream phosphorylation. Such models help distinguish between binding affinity and signaling efficacy in the endothelin response.
Knock-in
Knock-in of tagged endothelin peptides or receptors enables tracking of secretion, localization, and interaction dynamics in live cells and tissues. Tagged knock-in models are valuable for understanding how endothelin peptides are processed and released.
Overexpression
Overexpression of EDN1 or EDNRA can amplify the response to endothelin, mimicking disease states such as hypertension and pulmonary hypertension [1,7]. These models are useful for testing whether increased pathway activity is sufficient to drive pathological phenotypes.
How EDITGENE Supports response to endothelin Research
Researchers studying response to endothelin-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with its activation. CRISPR-based models provide the gold-standard approach for establishing causality, from receptor-ligand interactions to downstream physiological outputs. EDITGENE offers a comprehensive suite of services to generate and characterize such models efficiently.
Contact EDITGENE today to design your custom CRISPR model for response to endothelin research.
Frequently Asked Questions About response to endothelin
What is GO:1990839 response to endothelin?
GO:1990839 is a Gene Ontology biological process term describing any change in cell or organism state or activity resulting from an endothelin stimulus, where endothelin includes endothelin-1, -2, and -3.
What are endothelins?
Endothelins are three secretory vasoconstrictive peptides, endothelin-1, endothelin-2, and endothelin-3, that regulate vascular tone and other physiological processes.
What genes are involved in response to endothelin?
Key genes include EDN1, EDN2, EDN3, EDNRA, EDNRB, and downstream signaling genes such as PLCB1 and ITPR1 [2,5].
How does endothelin-1 cause vasoconstriction?
Endothelin-1 binds receptors on vascular smooth muscle, triggering inositol lipid signaling and calcium mobilization that lead to sustained contraction and pressor responses [2,5,8].
Is endothelin involved in hypertension?
Yes, endothelin contributes to hypertension and vascular remodeling, and pressor responses to endothelin differ in spontaneously hypertensive rats [4,8].
Does endothelin interact with angiotensin II?
Yes, endothelin-1 augments the pressor response to angiotensin II infusion in rats, showing crosstalk between the two systems.
Can endothelin affect uterine contraction?
Endothelin-1 potentiates the in vitro contractile response of pregnant human myometrium to oxytocin.
What is the role of inositol lipids in endothelin signaling?
Inositol lipid-mediated signaling is a key transduction mechanism in the response to endothelin, as shown in mammalian testis.
How can CRISPR help study response to endothelin?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of endothelin pathway genes in vitro and in vivo [1,5,7].
What diseases are linked to endothelin responses?
Hypertension, pulmonary hypertension, and cardiovascular remodeling are linked to endothelin responses [4,7,8].
Conclusion
GO:1990839 response to endothelin captures a fundamental biological process with profound implications for cardiovascular, pulmonary, and reproductive physiology. The pathway is driven by three vasoconstrictive peptides and involves receptor engagement, inositol lipid signaling, and potentiation of other hormonal systems [1,2,5,6]. Its dysregulation contributes to hypertension and pulmonary hypertension, making it a compelling target for mechanistic and therapeutic research [4,7,8]. CRISPR-based models offer powerful tools to dissect the causal roles of individual genes within this pathway, and EDITGENE provides end-to-end services to support such studies.
References
- 1. Yoshida K et al.. 1992. Endothelin-1 augments pressor response to angiotensin II infusion in rats.. Hypertension 20(3):292-7 PMID: 1516947
- 2. Lüscher TF. 1991. Endothelin.. J Cardiovasc Pharmacol 18 Suppl 10:S15-22 PMID: 1724999
- 4. Schiffrin EL. 1995. Endothelin in hypertension.. Curr Opin Cardiol 10(5):485-94 PMID: 7496057
- 5. Rudge SA et al.. 1995. Inositol lipid-mediated signalling in response to endothelin and ATP in the mammalian testis.. Mol Cell Biochem 149-150:161-74 PMID: 8569725
- 6. Valenzuela GJ et al.. 1995. Endothelin-1 potentiates the in vitro contractile response of pregnant human myometrium to oxytocin.. Am J Obstet Gynecol 172(5):1573-6 PMID: 7755074
- 7. Siemsen DW et al.. 2016. Vascular Dysfunction in Pneumocystis-Associated Pulmonary Hypertension Is Related to Endothelin Response and Adrenomedullin Concentration.. Am J Pathol 186(2):259-69 PMID: 26687815
- 8. Miyauchi T et al.. 1989. Characteristics of pressor response to endothelin in spontaneously hypertensive and Wistar-Kyoto rats.. Hypertension 14(4):427-34 PMID: 2676862
